1. The market is expected to grow at a compound annual growth rate of 4.6 percent from 2014 to 2019.
2. The main market driver is an increased interest in sports activities.
3. The main challenge facing the market is unfavorable reimbursement policies.
4. Key vendors in the market include Arthrex, Biomet, Smith & Nephew and Stryker.
More articles on devices:
Medtronic’s VERTEX Reconstruction System receives FDA approval for expanded indications
Sonoma Orthopedic Products receives FDA clearance for FibuLock Nail
Argus raises Integra Lifesciences’ price target to $61
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
